Cover Image
Market Research Report
Product code 
1031488

Hospital Acquired Infection Control Market Research Report by Type, by Pathogen Type, by Indication, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

Published: | 360iResearch LLP | 194 Pages | Delivery time: 1-2 business days

Price

Back to Top
Hospital Acquired Infection Control Market Research Report by Type, by Pathogen Type, by Indication, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published: October 5, 2021
360iResearch LLP
Content info: 194 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Global Hospital Acquired Infection Control Market size was estimated at USD 28.76 billion in 2020 and expected to reach USD 30.34 billion in 2021, at a CAGR 5.84% to reach USD 40.44 billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Hospital Acquired Infection Control to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Consumables, Disinfectants, Disinfectors, Endoscope Reprocessors, Infection Prevention & Surveillance Software, Microbial Testing Instruments, Others, Reagents, and Sterilizers.

Based on Pathogen Type, the market was studied across Bacterial, Fungal, and Viral.

Based on Indication, the market was studied across Bloodstream Infections, Gastrointestinal Infections, Hospital Acquired Pneumonia, Others, Surgical Site Infections, and Urinary Tract Infections.

Based on End User, the market was studied across Ambulatory Surgical & Diagnostic Centers, Hospitals & ICUs, and Nursing Homes & Maternity Centers.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hospital Acquired Infection Control Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hospital Acquired Infection Control Market, including 3M Company, Abbott Laboratories, Advanced Sterilization Products Services Inc., Becton, Dickinson and Company, Belimed AG, BioMerieux SA, Cantel Medical Corporation, F. Hoffmann-La Roche Ltd, Kimberly-Clark Corporation, Merck & Co., Inc., Olympus Corporation, Pfizer Inc., Sterigenics International LLC., Steris Corporation, and Synergy Health, PLC.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Hospital Acquired Infection Control Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hospital Acquired Infection Control Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hospital Acquired Infection Control Market?
  • 4. What is the competitive strategic window for opportunities in the Global Hospital Acquired Infection Control Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Hospital Acquired Infection Control Market?
  • 6. What is the market share of the leading vendors in the Global Hospital Acquired Infection Control Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Hospital Acquired Infection Control Market?
Table of Contents
Product Code: MRR-035590448001

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Dynamics

  • 5.1. Introduction
  • 5.2. Drivers
    • 5.2.1. Growing geriatric population with the increase in the number of chronic diseases
    • 5.2.2. Rapidly growing emphasis on infection control policies
    • 5.2.3. Increasing use of disinfectors and medical nonwovens in the healthcare industry
  • 5.3. Restraints
    • 5.3.1. Lack of awareness regarding hospital acquired infection
  • 5.4. Opportunities
    • 5.4.1. Increasing investments in R&D coupled with high usage of consumables in hospitals
    • 5.4.2. Innovative technologies implemented in devices that control infection
  • 5.5. Challenges
    • 5.5.1. Stringent regulatory requirements

6. Hospital Acquired Infection Control Market, by Type

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Disinfectants
  • 6.4. Disinfectors
  • 6.5. Endoscope Reprocessors
  • 6.6. Infection Prevention & Surveillance Software
  • 6.7. Microbial Testing Instruments
  • 6.8. Others
  • 6.9. Reagents
  • 6.10. Sterilizers

7. Hospital Acquired Infection Control Market, by Pathogen Type

  • 7.1. Introduction
  • 7.2. Bacterial
  • 7.3. Fungal
  • 7.4. Viral

8. Hospital Acquired Infection Control Market, by Indication

  • 8.1. Introduction
  • 8.2. Bloodstream Infections
  • 8.3. Gastrointestinal Infections
  • 8.4. Hospital Acquired Pneumonia
  • 8.5. Others
  • 8.6. Surgical Site Infections
  • 8.7. Urinary Tract Infections

9. Hospital Acquired Infection Control Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical & Diagnostic Centers
  • 9.3. Hospitals & ICUs
  • 9.4. Nursing Homes & Maternity Centers

10. Americas Hospital Acquired Infection Control Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Hospital Acquired Infection Control Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand

12. Europe, Middle East & Africa Hospital Acquired Infection Control Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Key Player
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. 3M Company
  • 14.2. Abbott Laboratories
  • 14.3. Advanced Sterilization Products Services Inc.
  • 14.4. Becton, Dickinson and Company
  • 14.5. Belimed AG
  • 14.6. BioMerieux SA
  • 14.7. Cantel Medical Corporation
  • 14.8. F. Hoffmann-La Roche Ltd
  • 14.9. Kimberly-Clark Corporation
  • 14.10. Merck & Co., Inc.
  • 14.11. Olympus Corporation
  • 14.12. Pfizer Inc.
  • 14.13. Sterigenics International LLC.
  • 14.14. Steris Corporation
  • 14.15. Synergy Health, PLC

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: MARKET DYNAMICS
  • FIGURE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2026
  • FIGURE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, 2018-2026 (USD BILLION)
  • FIGURE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2026 (USD BILLION)
  • FIGURE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTORS, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSORS, 2018-2026 (USD BILLION)
  • FIGURE 14. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSORS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INFECTION PREVENTION & SURVEILLANCE SOFTWARE, 2018-2026 (USD BILLION)
  • FIGURE 16. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INFECTION PREVENTION & SURVEILLANCE SOFTWARE, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 17. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MICROBIAL TESTING INSTRUMENTS, 2018-2026 (USD BILLION)
  • FIGURE 18. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MICROBIAL TESTING INSTRUMENTS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 19. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY OTHERS, 2018-2026 (USD BILLION)
  • FIGURE 20. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY OTHERS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 21. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REAGENTS, 2018-2026 (USD BILLION)
  • FIGURE 22. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REAGENTS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 23. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZERS, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZERS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2020 VS 2026 (%)
  • FIGURE 26. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2026
  • FIGURE 28. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BACTERIAL, 2018-2026 (USD BILLION)
  • FIGURE 29. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BACTERIAL, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 30. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY FUNGAL, 2018-2026 (USD BILLION)
  • FIGURE 31. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY FUNGAL, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY VIRAL, 2018-2026 (USD BILLION)
  • FIGURE 33. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY VIRAL, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 34. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
  • FIGURE 35. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2026
  • FIGURE 37. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, 2018-2026 (USD BILLION)
  • FIGURE 38. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2026 (USD BILLION)
  • FIGURE 40. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 41. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, 2018-2026 (USD BILLION)
  • FIGURE 42. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 43. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY OTHERS, 2018-2026 (USD BILLION)
  • FIGURE 44. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY OTHERS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 45. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2018-2026 (USD BILLION)
  • FIGURE 46. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 47. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, 2018-2026 (USD BILLION)
  • FIGURE 48. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 49. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 50. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
  • FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2026
  • FIGURE 52. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, 2018-2026 (USD BILLION)
  • FIGURE 53. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 54. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, 2018-2026 (USD BILLION)
  • FIGURE 55. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 56. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, 2018-2026 (USD BILLION)
  • FIGURE 57. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 58. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 59. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 60. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 61. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 62. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 63. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 64. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 65. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 66. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 67. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 68. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 69. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 70. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 71. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 72. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 73. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 74. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 75. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 76. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 77. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 78. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 79. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 80. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 81. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 82. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 83. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 84. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 85. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 86. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 87. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 88. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: FPNV POSITIONING MATRIX
  • FIGURE 89. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 90. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
  • TABLE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 6. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTORS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSORS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INFECTION PREVENTION & SURVEILLANCE SOFTWARE, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MICROBIAL TESTING INSTRUMENTS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY OTHERS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REAGENTS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 13. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZERS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 14. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2026 (USD BILLION)
  • TABLE 15. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 16. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY FUNGAL, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 17. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY VIRAL, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 18. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2026 (USD BILLION)
  • TABLE 19. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 20. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 21. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 22. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY OTHERS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 23. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 24. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 25. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
  • TABLE 26. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 27. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 28. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 29. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 30. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 31. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 32. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 33. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 34. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 35. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 36. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 37. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 38. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 39. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 40. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 41. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 42. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 43. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 44. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 45. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 46. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 47. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 48. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 49. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 50. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 51. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 52. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 53. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 54. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 55. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 56. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 57. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 58. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 59. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: SCORES
  • TABLE 60. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: BUSINESS STRATEGY
  • TABLE 61. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: PRODUCT SATISFACTION
  • TABLE 62. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: RANKING
  • TABLE 63. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 64. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: MERGER & ACQUISITION
  • TABLE 65. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 66. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 67. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: INVESTMENT & FUNDING
  • TABLE 68. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 69. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: LICENSE & PRICING